http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090086121-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1120d995ed76f52ba263e0d71cee10c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2007-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14256654798814b75f4e2116dbae59d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7119c957829ddffb63481f4dc1ea7b9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9dad416c7f65e9d5cbd42e6bb032db4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f901aa17d168f9bd63a18bb20d77c181
publicationDate 2009-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20090086121-A
titleOfInvention Crystalline Form Of Solvated Ilaprazole
abstract The present invention is directed to the crystalline form of solvated ilaprazole (2 [[(4-methoxy-3-methyl-2-pyridinyl) -methyl] sulfinyl] -5- (1H-pyrrol-1-yl) 1H-Benzimidazole). The present invention relates to a pharmaceutical composition which inhibits gastric acid secretion comprising an effective amount for gastric acid secretion and a crystalline ilaprazole hydrate based on the invention for a pharmaceutically acceptable carrier. The present invention also provides a treatment for the various acid related gastrointestinal diseases (GI) mentioned above.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102250509-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-019058-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011071314-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011071314-A2
priorityDate 2006-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457830921
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID214351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449263711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415893423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411174056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447685644
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22020343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454712420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID236409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505994
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409283606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10551
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415748160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID479

Total number of triples: 55.